Natixis’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
– Sell
-6,066
Closed -$321K – 892
2019
Q2
$321K Sell
6,066
-3,145
-34% -$167K ﹤0.01% 655
2019
Q1
$515K Sell
9,211
-2,142
-19% -$120K ﹤0.01% 659
2018
Q4
$596K Sell
11,353
-1,042
-8% -$59.3K ﹤0.01% 565
2018
Q3
$717K Sell
12,395
-1,862
-13% -$104K ﹤0.01% 597
2018
Q2
$810K Buy
14,257
+258
+2% +$14.7K ﹤0.01% 638
2018
Q1
$823K Buy
13,999
+2,782
+25% +$156K 0.01% 616
2017
Q4
$614K Buy
11,217
+2,544
+29% +$132K ﹤0.01% 568
2017
Q3
$410K Buy
+8,673
New +$408K ﹤0.01% 766

Other funds holding OFIX

Natixis's OFIX Position: Q3 2019 in Review

Natixis sold out of Orthofix Medical (OFIX) in Q3 2019, closing a stake of 6,066 shares — an estimated $321K sold.

Natixis first reported a position in OFIX in Q3 2017 and held it in 8 quarters. The position peaked at $823K in Q1 2018. 158 funds tracked by Wall St. Rank hold OFIX as of Q3 2019.

  • Natixis reported no remaining Orthofix Medical position as of Q3 2019 after selling out during the quarter.
  • Natixis sold 6,066 Orthofix Medical shares in Q3 2019, an estimated $321K.
  • Natixis first reported a position in Orthofix Medical in Q3 2017 and held it in 8 quarters.
  • Natixis's Orthofix Medical position peaked at $823K in Q1 2018.
  • 158 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2019.

Based on Natixis's 13F filing for Q3 2019, filed 13 Nov 2019.